Hospital Profile
Name | Clay County Hospital |
---|
Type | Critical Access Hospital |
---|
Location | 911 Stacy Burk Drive, Flora, Illinois |
---|
Ownership | Government - Local |
---|
Emergency Services | Yes |
---|
Medicare ID (CCN) | 141351 |
Patients' Experience Survey:
Willingness to Recommend Hospital:
Yes Patients who reported YES, they would definitely recommend the hospital
Probably Patients who reported YES, they would probably recommend the hospital
No Patients who reported NO, they would probably not or definitely not recommend the hospital
Cleanliness of Hospital Environment:
Always Patients who reported that their room and bathroom were "Always" clean
Usually Patients who reported that their room and bathroom were "Usually" clean
Sometimes or Never Patients who reported that their room and bathroom were "Sometimes" or "Never" clean
Quietness of Hospital Environment:
Always Patients who reported that the area around their room was "Always" quiet at night
Usually Patients who reported that the area around their room was "Usually" quiet at night
Sometimes or Never Patients who reported that the area around their room was "Sometimes" or "Never" quiet at night
Always Patients who reported that their nurses "Always" communicated well
Usually Patients who reported that their nurses "Usually" communicated well
Sometimes or Never Patients who reported that their nurses "Sometimes" or "Never" communicated well
Always Patients who reported that their doctors "Always" communicated well
Usually Patients who reported that their doctors "Usually" communicated well
Sometimes or Never Patients who reported that their doctors "Sometimes" or "Never" communicated well
Responsiveness of Hospital Staff:
Always Patients who reported that they "Always" received help as soon as they wanted
Usually Patients who reported that they "Usually" received help as soon as they wanted
Sometimes or Never Patients who reported that they "Sometimes" or "Never" received help as soon as they wanted
Communication about Medicines:
Always Patients who reported that staff "Always" explained about medicines before giving it to them
Usually Patients who reported that staff "Usually" explained about medicines before giving it to them
Sometimes or Never Patients who reported that staff "Sometimes" or "Never" explained about medicines before giving it to them
Yes Patients who reported that YES, they were given information about what to do during their recovery at home
No Patients who reported that NO, they were not given information about what to do during their recovery at home
Always Patients who "Strongly Agree" they understood their care when they left the hospital
Usually Patients who “Agree” they understood their care when they left the hospital
Sometimes or Never Patients who “Disagree” or “Strongly Disagree” they understood their care when they left the hospital
NPI Associated with the Hospital:
Unlike individual providers, Hospitals may have multiple NPI numbers for example, there can be a separate NPI for each unit within the hospital. We have found possible NPI number/s associated with Clay County Hospital from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.
NPI Number | 1184655136 |
Organization Name | COUNTY OF CLAY |
Doing Business As | CLAY COUNTY HOSPITAL |
Address | 911 Stacey Burk Dr, Flora, IL 62839 |
Hospital Type | General Acute Care Hospital |
Phone Number | 618-662-2131 |
News Archive
New low-energy method for terminating cardiac fibrillation
An international team of scientists from the Max-Planck-Institute for Dynamics and Self-Organization, Cornell University the Ecole Normale Supérieure de Lyon, the University Medicine Göttingen, the Rochester Institute of Technology, and the Institut Non-Linéaire de Nice have developed a new low-energy method for terminating life-threatening cardiac fibrillation of the heart.
Endothelial colony-forming cells show promise against inflammatory bowel disease
New research shows that a special population of stem cells found in cord blood has the innate ability to migrate to the intestine and contribute to the cell population there, suggesting the cells' potential to treat inflammatory bowel disease (IBD).
Phase I clinical trial results of AE37 in prostate cancer patients presented at EAU Congress
Generex Biotechnology Corporation today announced presentation of additional results from a recently completed Phase I clinical trial of its novel immunotherapeutic peptide AE37 in prostate cancer patients. AE37 is a synthetic cancer vaccine being developed by Antigen Express, Inc., a wholly owned subsidiary of Generex, for multiple cancer indications.
Study shows Levitra enhances patients' self-esteem by improving erections
The first clinical study to evaluate LEVITRA™ (vardenafil HCl) in men with mild Major Depressive Disorder (MDD) and erectile dysfunction (ED) showed LEVITRA produced statistically significant improvements over baseline in all measures of erectile function (EF) and depression/self-esteem. In the study, men taking Levitra were nearly three times more likely to report improved erections than men taking placebo.
Read more Medical News
› Verified 6 days ago
Structural Quality Measures:
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
New low-energy method for terminating cardiac fibrillation
An international team of scientists from the Max-Planck-Institute for Dynamics and Self-Organization, Cornell University the Ecole Normale Supérieure de Lyon, the University Medicine Göttingen, the Rochester Institute of Technology, and the Institut Non-Linéaire de Nice have developed a new low-energy method for terminating life-threatening cardiac fibrillation of the heart.
Endothelial colony-forming cells show promise against inflammatory bowel disease
New research shows that a special population of stem cells found in cord blood has the innate ability to migrate to the intestine and contribute to the cell population there, suggesting the cells' potential to treat inflammatory bowel disease (IBD).
Phase I clinical trial results of AE37 in prostate cancer patients presented at EAU Congress
Generex Biotechnology Corporation today announced presentation of additional results from a recently completed Phase I clinical trial of its novel immunotherapeutic peptide AE37 in prostate cancer patients. AE37 is a synthetic cancer vaccine being developed by Antigen Express, Inc., a wholly owned subsidiary of Generex, for multiple cancer indications.
Study shows Levitra enhances patients' self-esteem by improving erections
The first clinical study to evaluate LEVITRA™ (vardenafil HCl) in men with mild Major Depressive Disorder (MDD) and erectile dysfunction (ED) showed LEVITRA produced statistically significant improvements over baseline in all measures of erectile function (EF) and depression/self-esteem. In the study, men taking Levitra were nearly three times more likely to report improved erections than men taking placebo.
Read more News
› Verified 6 days ago